Importantly, if Hb screening alone had been undertaken, directing iron on the basis of anemia would result in two thirds of iron‐replete ß‐thalassemia carriers (in whom iron supplementation may result in loading) receiving iron, whereas directing iron based on hepcidin could reduce this to only 29% of carriers. Here, HAMP is linked to anemia.